688105 Nanjing Vazyme Biotech

Watchlist

Market Closed Jan 22 15:00 CST

8.05BMarket Cap339.15P/E (TTM)

Nanjing Vazyme Biotech Key Stats

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2023/Q3	298.258M / 308.385M	--
Aug 30, 2023	2023/Q2	268.843M / 322.185M	--

DatePeriodRevenue/EstimateEarnings Call

--2023/Q3298.258M / 308.385M--

Aug 30, 20232023/Q2268.843M / 322.185M--

--------

Unlock Free Earnings Estimates

Open Account

Novi Zam: Novi Zam 2024 annual results forecast

Jan 16 11:00 ET

Novi Zan 2024 annual results forecast

Jan 16 11:00 ET

Novi Zam: third quarter report 2024

Oct 30, 2024 12:00 ET

Third Quarter Report 2024

Oct 30, 2024 12:00 ET